Transcription factors in the pathogenesis of pulmonary arterial hypertension-Current knowledge and therapeutic potential.

Autor: Körbelin J; ENDomics Lab, Department of Medicine, Center of Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Klein J; ENDomics Lab, Department of Medicine, Center of Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Division of Pneumology and Center for Pulmonary Arterial Hypertension Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Matuszcak C; ENDomics Lab, Department of Medicine, Center of Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Division of Pneumology and Center for Pulmonary Arterial Hypertension Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Runge J; ENDomics Lab, Department of Medicine, Center of Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Division of Pneumology and Center for Pulmonary Arterial Hypertension Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Harbaum L; Division of Pneumology and Center for Pulmonary Arterial Hypertension Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Klose H; Division of Pneumology and Center for Pulmonary Arterial Hypertension Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Hennigs JK; ENDomics Lab, Department of Medicine, Center of Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Division of Pneumology and Center for Pulmonary Arterial Hypertension Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Publikováno v: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2023 Jan 06; Vol. 9, pp. 1036096. Date of Electronic Publication: 2023 Jan 06 (Print Publication: 2022).

CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivo.

Autor: Oh-Hohenhorst SJ; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Tilki D; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Ahlers AK; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Suling A; Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Hahn O; Department of Urology, University Medical Center Goettingen, Göttingen, Germany., Tennstedt P; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Matuszcak C; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany., Maar H; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany., Labitzky V; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany., Hanika S; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany., Starzonek S; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany., Baumgart S; Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Robert-Koch-Strasse 40, 37075, Goettingen, Germany.; Research & Development, Pharmaceuticals, Bayer AG, Müllerstr. 178, 13353, Berlin, Germany., Johnsen SA; Gene Regulatory Mechanisms and Molecular Epigenetics Lab, Gastroenterology Research, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA., Kluth M; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Sirma H; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Simon R; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Sauter G; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Huland H; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schumacher U; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany., Lange T; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. to.lange@uke.de.

Publikováno v: Cancer gene therapy [Cancer Gene Ther] 2022 Jan; Vol. 29 (1), pp. 49-61. Date of Electronic Publication: 2021 Jan 07.

Vascular Endothelial Cells: Heterogeneity and Targeting Approaches.

Autor: Hennigs JK; ENDomics Lab, Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Matuszcak C; ENDomics Lab, Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Trepel M; Department of Hematology and Medical Oncology, University Medical Center Augsburg, 86156 Augsburg, Germany., Körbelin J; ENDomics Lab, Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Publikováno v: Cells [Cells] 2021 Oct 10; Vol. 10 (10). Date of Electronic Publication: 2021 Oct 10.

Spezifische miRNA-Signaturen Chemotherapie-resistenter Ösophaguskarzinomzellinien sind verantwortlich für deren Chemotherapie-resistenten Phänotyp

Autor: Matuszcak, C, Lindner, K, Haier, J, Hummel, R

Publikováno v: 132. Kongress der Deutschen Gesellschaft für Chirurgie; 20150428-20150501; München; DOC15dgch491 /20150424/

Einleitung: Chemotherapieresistenzen sind ein grosses, klinisch relevantes Problem bei der Behandlung des Ösophaguskarzinoms. Wir konnten kürzlich spezifische miRNA-Signaturen in Cisplatin- und 5-Fluorouracil-resistenten Ösophaguskarzinomzellen id

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87d27556fef8d979da11585994ddebf4

Cardiovascular Risk in Patients with Inflammatory Bowel Diseases—The Role of Endothelial Dysfunction.

Autor: Livzan, Maria A.¹ (AUTHOR) mlivzan@yandex.ru, Bikbavova, Galiya R.² (AUTHOR) galiya1976@mail.ru, Lisyutenko, Natalya S.² (AUTHOR), Romanyuk, Alisa E.³ (AUTHOR) romalisa00@mail.ru, Drapkina, Oxana M.⁴ (AUTHOR) drapkina@bk.ru

Publikováno v: Diagnostics (2075-4418). Aug2024, Vol. 14 Issue 16, p1722. 15p.